USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/9007
Full metadata record
DC FieldValueLanguage
dc.contributor.authorCeban, Emil
dc.contributor.authorTănase, Adrian
dc.contributor.authorLupaşco, Constantin
dc.contributor.authorGalescu, Andrei
dc.contributor.authorBotnari, Vasile
dc.contributor.authorRusanovschii, V.
dc.date.accessioned2020-05-02T10:34:24Z
dc.date.available2020-05-02T10:34:24Z
dc.date.issued2011
dc.identifier.citationCEBAN, E., TĂNASE, A., LUPAŞCO, C., et al. Prostamol ®Uno în tratamentul pacienţilor cu hiperplazie benignă de prostată (experienţa de 10 ani). In: Arta Medica. 2011, nr. 2(45), pp. 35-38. ISSN 1810-1852.en_US
dc.identifier.issn1810-1852
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/9007
dc.descriptionCatedra Urologie şi Nefrologie Chirurgicală USMF „N. Testemiţanu”, Spitalul Raional Edineţ; Secţia Urologie IMSP Spitalul Clinic Republican, Al V-lea Congres de Urologie, Dializă şi Transplant Renal din Republica Moldova cu participare internaţională (1-13 iunie 2011)en_US
dc.description.abstractSummary. During 10 years, between 2001-2011, 760 patients with BPH were treated with Prostamol®Uno, 320mg, daily. In this trial patients were assessed pre- and post- treatment with International Prostate Symptom Score (IPSS), the Quality of Life (QOL), values of PSA and volume of residual urine appreciated ecographically. The analysis of our data shows decrease in IPSS score, QOL and volume of residual urine with in 53,4 %, 57,5% and 48,7% respectively. Prostamol®Uno is one of election drug in conservative treatment of BPH.en_US
dc.language.isoroen_US
dc.publisherAsociaţia chirurgilor “Nicolae Anestiadi” din Republica Moldovaen_US
dc.subject.meshProstatic hyperplasia--drug therapyen_US
dc.subject.meshAdrenergic alpha-1 receptor antagonistsen_US
dc.subject.meshAdrenergic alpha-Antagonists--therapeutic useen_US
dc.subject.meshPlant extracts--therapeutic useen_US
dc.subject.meshPlant extracts--administration & dosageen_US
dc.subject.meshProstamol Uno--therapeutic useen_US
dc.titleProstamol®Uno în tratamentul pacienţilor cu hiperplazie benignă de prostată (experienţa de 10 ani)ro
dc.title.alternativeProstamol®Uno in treatment of the patients with benign prostatic hyperplasia (experience of 10 years)en_US
dc.typeArticleen_US
Appears in Collections:Arta Medica Vol. 45 No.2, 2011 ediţie specială

Files in This Item:
File Description SizeFormat 
PROSTAMOL_r_UNO_IN_TRATAMENTUL_PACIENTILOR.pdf229.07 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback